Avid Bioservices, Inc. (CDMO): Price and Financial Metrics
CDMO Price/Volume Stats
| Current price | $12.49 | 52-week high | $12.51 |
| Prev. close | $12.48 | 52-week low | $5.90 |
| Day low | $12.47 | Volume | 3,067,700 |
| Day high | $12.51 | Avg. volume | 1,438,209 |
| 50-day MA | $12.35 | Dividend yield | N/A |
| 200-day MA | $10.22 | Market Cap | 798.90M |
CDMO Stock Price Chart Interactive Chart >
Avid Bioservices, Inc. (CDMO) Company Bio
Avid Bioservices, Inc., formerly Peregrine Pharmaceuticals, researches and develops monoclonal antibodies for the treatment of cancer in the United States. Its lead immunotherapy candidate includes bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company was founded in 1981 and is based in Tustin, California.
CDMO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CDMO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | 1.79% |
| 1-year | 56.91% |
| 3-year | -10.21% |
| 5-year | 95.77% |
| YTD | 1.13% |
| 2024 | 90.00% |
| 2023 | -52.80% |
| 2022 | -52.81% |
| 2021 | 152.86% |
| 2020 | 50.46% |